EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis

Kaihao Lin iD, Lifang Huang, Yadong Wang, Kangkang Li, Yuanning Ye, Siqi Yang, Aimin Li

Helicobacter · 2023-12 · 28 (6)

DOI: 10.1111/hel.13015 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Helicobacter, online erschienen am 27.08.2023. Verfasst von Kaihao Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Guangdong Medical Research Foundation, Special Project for Research and Development in Key areas of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The prevalence of antibiotic resistance for Helicobacter pylori ( H. pylori ) has been increasing over the year, making it more difficult for traditional empirical therapy to successfully eradicate H. pylori . Thus, tailored therapy (TT) guided by molecular‐based antibiotic susceptibility testing (AST) has been frequently recommended. We conducted a single‐arm meta‐analysis to determine the efficacy of tailored therapy guided by molecular‐based AST.

Methods

A systematic literature review was performed on multiple databases, and studies on molecular‐based TT were included. The eradication rates of TT by intention‐to‐treat (ITT) and per‐protocol (PP) analyses were pooled respectively.

Results

A total of 35 studies from 31 literature (4626 patients) were included in the single‐arm meta‐analysis. Overall, the pooled eradication rate of TT was 86.9% (95% CI:84.7%–89.1%) by the ITT analysis, and 91.5% (95% CI:89.8%–93.2%) by PP analysis. The pooled eradication rates of first‐line TT and rescue TT were 86.6% and 85.1% by ITT analysis and 92.0% and 87.9% by PP analysis, respectively. When tailored rescue therapy was based on the genotypic resistance to at least four antibiotics, the pooled eradication rates reached 89.4% by ITT analysis and 92.1% by PP analysis. For genotype‐susceptive strains, the pooled eradication rate of TT with targeted antibiotics was 93.1% (95% CI:91.3%–94.9%), among which the pooled eradication rate of tailored bismuth quadruple therapy was the highest (94.3%). Besides, the eradication rate of 7‐day TT or tailored triple therapy without bismuth for genotype‐susceptive strains could both reach more than 93.0%.

Conclusion

Tailored therapy guided by molecular‐based AST can achieve somewhat ideal therapeutic outcomes. TT with a 7‐day duration or without bismuth for genotype‐susceptible strains can achieve good eradication efficacy. The effectiveness of TT can be improved to some extent by expanding the coverage of AST or by adding bismuth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriHumansBismuthMetronidazoleDrug Therapy, CombinationAnti-Bacterial AgentsGenotypeTreatment OutcomeAmoxicillinProton Pump Inhibitors

Stichwörter der Autor:innen

Helicobacter pylorimeta-analysismolecular-based antibiotic susceptibility testingtailored therapy

Substanzen

BismuthMetronidazoleAnti-Bacterial AgentsAmoxicillinProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Gastroenterology, Laboratory Department of Baiyun Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Department of Digestive Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Kaihao Lin

Förderung

  • Guangdong Medical Research Foundation
  • Special Project for Research and Development in Key areas of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Health Appropriate Technology Popularization Project of Guangdong Province

Zitieren

APA

Lin, K., Huang, L., Wang, Y., Li, K., Ye, Y., Yang, S., & Li, A. (2023). Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis. Helicobacter, 28(6). https://doi.org/10.1111/hel.13015

Vancouver

Lin K, Huang L, Wang Y, Li K, Ye Y, Yang S, et al. Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis. Helicobacter. 2023;28(6). doi:10.1111/hel.13015

BibTeX
@article{Lin2023,
  author = {Lin, Kaihao and Huang, Lifang and Wang, Yadong and Li, Kangkang and Ye, Yuanning and Yang, Siqi and Li, Aimin},
  title = {Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis},
  journal = {Helicobacter},
  year = {2023},
  volume = {28},
  number = {6},
  doi = {10.1111/hel.13015}
}
Kostenlos starten →